M. Racke

Defining Clinical and Immunological Predictors of Poor Immune Responses to COVID-19 mRNA Vaccines in Patients with Primary Antibody Deficiency

R. Bucala, M. Shin, I. Kang, 2022, Journal of Clinical Immunology.

Recurrent Optic Neuritis and Perineuritis Followed by an Unexpected Discovery

S. Galetta, J. Graves, S. Zamvil, 2022, Neurology: Neuroimmunology & Neuroinflammation.

Potential risk of progressive multifocal leukoencephalopathy with natalizumab therapy: possible interventions.

H. Hartung, B. Hemmer, C. Marra, 2007, Archives of neurology.

Risk of new disease activity in patients with multiple sclerosis who continue or discontinue disease-modifying therapies (DISCOMS): a multicentre, randomised, single-blind, phase 4, non-inferiority trial

A. Cross, Aaron E Miller, M. Goldman, 2023, The Lancet Neurology.